Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Medicine

formerly Central European Journal of Medicine

Editor-in-Chief: Darzynkiewicz, Zbigniew

1 Issue per year

IMPACT FACTOR 2017: 0.484
5-year IMPACT FACTOR: 0.484

CiteScore 2017: 0.53

SCImago Journal Rank (SJR) 2017: 0.154
Source Normalized Impact per Paper (SNIP) 2017: 0.264

ICV 2017: 152.94

Open Access
See all formats and pricing
More options …
Volume 7, Issue 6


Volume 10 (2015)

The basis of the discovery process for a new pharmaceutical product

Veselin Dickov
Published Online: 2012-10-11 | DOI: https://doi.org/10.2478/s11536-012-0080-2


The basis of the discovery process for a new pharmaceutical product is in understanding the mechanism of action of a particular disease or processes in the organism related to the disease and/or its symptoms. The essence of a pharmaceutical is in the active ingredient capable of affecting processes within the organism beneficially. The discovery process includes a particular sequence of activities of various profiles of experts, about which various authors agree. The history of pharmaceutical industry (and pharmacy) is measured from one discovery of an innovative drug or approach to treatment of a particular disease to the next one. The cost of pharmaceutical products is one of the key causes of controversy related to this industry. Numerous cultures have proverbs expressing the opinion that health is priceless or that health is the greatest wealth. What if health does have a price? One of the basic premises of marketing is that price should reflect consumer value.

Keywords: Pharmaceutical market; New drug development; Pricing regulations; The cost of pharmaceutical products

  • [1] Dickov V., Kuzman B. (2011) ”Analyzing Pharmaceutical Industry” National Journal of Physiology, Pharmacy and Pharmacology. NJPPP.; 1(1): pp. 1–8 Google Scholar

  • [2] Suhrcke M, McKee M, Sauto Arce R. Tsolova S. and Mortensen J. (2005): The contribution of health to the economy in the European Union. European Commission. Office for Official Publications of the European Communities. Luxembourg, No 3, pp. 373–377 Google Scholar

  • [3] Dickov V. Dickov A. Milicevic B., (2010) “Freedom from disease — Health protection system in Serbia — management approach”, International Journal, Total Quality Management & Excellence, Vol. 38, No. 2, pp.119–126 Google Scholar

  • [4] Franklin J. Carter, Ravindra Chitturi, Segmentation Based on Physicians Behavior(2009): Implications for Sales forecasting and Marketing-mix Strategy; Journal of Personal Selling & Sales Management, Vol.XXIX, No. 1, pp. 123–134 Google Scholar

  • [5] Gagan Bhalla, Theodoros Evgeniou, Leonard Lerer, (2004) Customer Relationship Management and Networked Healthcare in the Pharmaceutical Industry; International Journal of Medical Marketing, Vol.4, pp. 34–35 http://dx.doi.org/10.1057/palgrave.jmm.5040188CrossrefGoogle Scholar

  • [6] Gregory T. Gundlach, (2007) The American Marketing Association’s 2004 Definition of marketing: perspectives on Its Implications for Scholarship and the Role and Responsibility of marketing in Society; Journal of Public Policy & Marketing, Fall, Vol. 26(2). pp. 234–245 Google Scholar

  • [7] Jennz Darroch, Morgan P. Miles, Andrew Jardine, Ernest F. Cooke, (2004) The AMA Definition of Marketing and its Relationship to a Market Orientation: An Extension of Cooke, Rayburn, & Abercrombie; Journal of Marketing Theory and Practice Fall, No 1, pp. 12–15 Google Scholar

  • [8] Dickov V., Nerandjic B.and Perovic V: (2004) “Ekonomika moderna” Stilos, FTN, Novi Sad 2004. Vol 1, No 1, pp. 9–23 Google Scholar

  • [9] Sandier S., et al: (2004) Health Care Systems in Transition, Edited by: Sarah Thomson and Elias Mossialos, WHO — Regional Office for Europe, No 1, pp.45–51 Google Scholar

  • [10] Alfred D. Chandler Jr., (2005) Shaping the Industrial Century: The Remarkable Story of the Evolution of the Modern Chemical and Pharmaceutical Industries; Harvard University Press, London, UK, Vol.1, No 1, pp. 36–39 Google Scholar

  • [11] Fran Hawthorne, (2005) Inside the FDA: The Business and Politics Behind the Drugs We Take and the Food We Eat; John Wiley & Sons, Inc., Hoboken, New Jersey, USA Vol.3 No 3, pp. 56–67 Google Scholar

  • [12] Frank Bradley, (2009) Strategic Marketing In the Customer Driven Organization; John Wiley and Sons, Chichester, West Sussex, England, No. 3, pp. 89–90 Google Scholar

  • [13] Dickov V., Kuzman B. “The Promotion of Pharmaceutical Products”, Materia Socio Medica 2011. Volume 23. Number 1. Pp. 48–59 Google Scholar

  • [14] Henry Mintzberg, James Brian Quinn, Sumantra Ghoshal, (2010) The Strategy Process; Prentice Hall Europe, Hertfordshire, UK, No. 1, pp.76–78 Google Scholar

  • [15] Kate Gillespie, Jeannet Jean-Pierre, Hennessey H. David, (2009) Global Marketing; Houghton Mifflin Company, Boston, USA, Vol. 1, No 3, pp. 60–62 Google Scholar

  • [16] Emira Kahrovic “Chemical feature of inorganic compounds as anticancer agents” HealthMED — Volume 5. Number 5. 2011. pp.1112–1117 Google Scholar

  • [17] Dickov A., Vuckovic N., Dickov V., S. Martinović- Mitrović “Post traumatic stress disorder (PTSD) after traffic accident — PTSD and traffic accidents”. HealthMED — Volume 4/Number 4/Supplement 1/2010. pp.1037–1043 Google Scholar

  • [18] Orville C. Walker Jr., Harper W. Boyd Jr., John Mullins, Jean-Claude Larreche, (2010) Marketing Strategy: A Decision-Focused Approach; McGraw-Hill Irwin, New York, Vol.1, pp. 223–229 Google Scholar

  • [19] Robert F. Dyer, Ernest H. Forman, An Analitic Approach to Marketing Decisions; Prentice Hall, New Yersey, USA, 1991. pp.107–110 Google Scholar

  • [20] Dickov V., Mitrovic D., Kuzman B., HEALTHY IN TRANSITION — Private or government health institutions — Patient choice,, Case Study Case Rep. 2011; 1 pp. 61–73 Google Scholar

  • [21] Tom Blackett, Rebecca Robins, Brand Medicine, The Role of Branding in the Pharmaceutical Industry; Palgrave, New York, USA, 2002 pp.98–103 Google Scholar

  • [22] William O. Bearden, Thomas N. Ingram, Raymond W. Longest J.B. Rakich J.S. and Darr K. Managing: Health Service Organization and Systems, London (1993) pp. 234–256 Google Scholar

About the article

Published Online: 2012-10-11

Published in Print: 2012-12-01

Citation Information: Open Medicine, Volume 7, Issue 6, Pages 691–699, ISSN (Online) 2391-5463, DOI: https://doi.org/10.2478/s11536-012-0080-2.

Export Citation

© 2012 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Comments (0)

Please log in or register to comment.
Log in